ROLE OF THE CD14 LPS RECEPTOR IN CORNEAL INFLAMMATION

CD14 LPS 受体在角膜炎症中的作用

• 批准号: 2840475
• 负责人: JOHN C ANSEL
• 金额: $ 26.8万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-05-01 至 2004-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2840475
• 关键词: CD14 molecule; Pseudomonas; biological signal transduction; cell adhesion molecules; cornea disorder; enzyme activity; enzyme linked immunosorbent assay; flow cytometry; genetically modified animals; human tissue; immunocytochemistry; inflammation; keratitis; laboratory mouse; nuclear factor kappa beta; organ culture; pathologic process; phosphorylation; polymerase chain reaction; protein tyrosine kinase; receptor expression; tumor necrosis factor alpha

Gram negative infections of the cornea with organisms such as Pseudomonas can have profound consequences for patients including bacterial keratitis which can lead to visual loss. A significant portion of the inflammatory response to Pseudomonas is mediated by LPS. We have recently reported that the cornea expresses one of the principal LPS receptors, CDI4. The long-term goal of this project is to determine the role of the cornea itself in mediating host innate immune responses to bacterial infections. This application will test the hypothesis that corneal cells express functional CD14 receptors that, when activated by LPS, are capable of triggering the expression of proinflammatory peptides which facilitate the host resolution of gram negative corneal infections. To experimentally test this hypothesis, we will undertake the following Specific Aims: SPECIFIC AIM #1: To examine the expression and regulation of the CD14 receptor in the cornea; SPECIFIC AIM #2: To assess the functional competence of corneal CD14 receptors; SPECIFIC AIM #3: To assess the ability of CD14 activation to induce innate inflammatory responses in the cornea; and SPECIFIC AIM #4: To determine the in vivo role of the corneal CD14 receptor in mediating corneal inflammatory responses in a murine experimental model of Pseudomonas bacterial keratitis. To carry out these studies, human and murine corneal cells and corneal tissue will be used as well as genetically altered strains of mice in which CD14 expression is absent, diminished, or overexpressed. Cornea CD14 expression will be measured constitutively and after exposure to bacterial reagents (Pseudomonas, LPS, LPS/LBP) and cytokines (IL-1 and TNFa). CD14 functional activity to bacterial reagents will be measured by intracellular calcium responses, tyrosine kinase activity, and NF-kappaB activity. Corneal CD14 induced innate inflammatory responses to bacterial reagents will be determined by measuring the expression of corneal cytoidnes (IL-I, IL-6, and TNFa), chemokines (IL-8), and cell adhesion molecules (ICAM-1). A murine model using CD14 genetically altered animals will be utilized to assess the in vivo role of CDI4 in experimental Pseudomonas bacterial keratitis. The activation of corneal CD14 may have both beneficial and detrimental inflammatory responses. Understanding the role of CD14 in mediating corneal innate immunity may result in novel approaches to the management of corneal infectious diseases.

革兰氏阴性角膜感染，如假单胞菌，可对患者造成严重后果，包括细菌性角膜炎，可导致视力丧失。假单胞菌的炎症反应有很大一部分是由LPS介导的。我们最近报道了角膜表达一种主要的LPS受体CDI4。该项目的长期目标是确定角膜本身在介导宿主对细菌感染的先天免疫反应中的作用。该应用将验证角膜细胞表达功能性CD14受体的假设，当被LPS激活时，该受体能够触发促炎肽的表达，从而促进宿主对革兰氏阴性角膜感染的解决。为了实验验证这一假设，我们将进行以下具体目标：具体目标#1：检查CD14受体在角膜中的表达和调控；特异性目的2：评估角膜CD14受体的功能能力；特异性目的#3：评估CD14激活诱导角膜先天炎症反应的能力；目的4：在假单胞菌细菌性角膜炎小鼠实验模型中，确定角膜CD14受体在介导角膜炎症反应中的体内作用。为了开展这些研究，将使用人类和小鼠的角膜细胞和角膜组织，以及CD14表达缺失、减少或过度表达的转基因小鼠。在暴露于细菌试剂（假单胞菌，LPS, LPS/LBP）和细胞因子（IL-1和TNFa）后，将组成性地测量角膜CD14的表达。CD14对细菌试剂的功能活性将通过细胞内钙反应、酪氨酸激酶活性和NF-kappaB活性来测量。通过测量角膜细胞素（il -1、IL-6和TNFa）、趋化因子（IL-8）和细胞粘附分子（ICAM-1）的表达，可以确定角膜CD14诱导的对细菌试剂的先天性炎症反应。使用CD14转基因动物的小鼠模型将用于评估CDI4在实验性假单胞菌细菌性角膜炎中的体内作用。角膜CD14的激活可能有有益和有害的炎症反应。了解CD14在介导角膜先天免疫中的作用可能会导致角膜感染性疾病治疗的新方法。